The endometrium plays a key role in reproduction, and this function is tightly regulated by endogenous and xenobiotic steroids. Sulphation, catalysed by members of the sulphotransferase (SULT) enzyme family, is a major deactivating mechanism for steroid hormones and we have investigated the expression and regulation in vivo of SULT in the human endometrium. In the normal cycling endometrium, expression of the phenol sulphotransferases SULT1A1 and SULT1A3 and the oestrogen sulphotransferase SULT1E1 were observed, with SULT1A1 and SULT1E1 expression being higher in the luteal phase than in the follicular phase. No expression of the hydroxysteroid sulphotransferase SULT2A1 was detected at any time in the endometrium. In endometrium from women taking the combined oral contraceptive pill (OCP), SULT1E1 expression was virtually absent, and SULT1A1 expression was substantially reduced. Similarly, in early pregnancy (i.e. first trimester) endometrium, SULT1E1 expression was absent, although SULT1A1 and SULT1A3 expression were unaffected. Our results with normal endometrium support in-vitro data showing that SULT1E1 expression is regulated by progesterone. However, the data obtained from OCP and early pregnancy endometrium suggest that factors other than the concentration of circulating progesterone are involved in the regulation of the expression of this important enzyme in the endometrium.
Introduction
hydrolyses the sulphates of various steroid hormones, including oestrogens, and therefore contributes to 'sulphation' overall) The monthly cyclical changes in endometrial morphology, throughout the menstrual cycle (Prost and Adessi, 1983) . Also, physiology and biochemistry are strongly influenced by ovarian the k M for ARSC is considerably higher than that for oestrogen steroids (principally 17β-oestradiol and progesterone), and sulphotransferase (Prost and Adessi, 1983; Zhang et al., 1998) , serve to prepare an environment able to accept and implant a suggesting that sulphation may predominate over sulphate fertilized embryo. In most mammalian species progesterone conjugate hydrolysis in the presence of low concentrations of appears to be essential for implantation, whereas oestrogen is oestrogen. These oestrogen-metabolizing enzymes probably permissive but not essential (Ghosh and Sengupta, 1995) . In serve to protect the endometrium from excess oestrogenic humans the exact (steroid) hormonal requirement within the stimulation at this critical period of the reproductive cycle, intrauterine environment during the peri-implantation period since overstimulation by oestrogen prior to implantation has is unknown, although the endometrium is capable of oestrogen been implicated as a risk factor in failure to establish pregnancy synthesis (Tseng et al., 1982; Tseng, 1984) and the peri- (Olson et al., 1983; Sterzik et al., 1988) . Thus it is likely implantation conceptus secretes oestrogen (Edgar et al., 1993) .
that a delicate balance exists between progesterone/oestrogenThe mid luteal phase production of oestrogen by the ovary mediated preparation of the endometrium for implantation and and conceptus is complemented by progesterone-dependent the enzymatic mechanisms for protecting the endometrium increases in the oestrogen-metabolizing enzymes 17β-hydroxyagainst excessive oestrogenic stimulation. Factors that disrupt steroid dehydrogenase type 2 (Tseng and Gurpide, 1975, 1979;  this hormonal regulation of the process of implantation are Casey et al., 1994) and oestrogen sulphotransferase (Buirchell likely to affect reproductive potential and may therefore and Hähnel, 1975; Tseng and Liu, 1981; Clarke et al., 1982) contribute to infertility (Fauser and Hsueh, 1995) . Sulphation and a decrease in oestrogen receptor levels (Hsueh et al., plays a key role in steroid hormone function (Roy, 1992; 1976; Lessey et al., 1988; Snijders et al., 1992; Noe et al., Strott, 1996) SULT1E1) which displays high affinity for endogenous and xenobiotic oestrogens (Aksoy et al., 1994; Forbes-Bamforth Tissue collection and processing and Coughtrie, 1994; Falany et al., 1995) .
Patients with irregular menstrual cycles or who were on regular medica-
The endometrium has the capacity to sulphate oestrogens, tion were excluded from the study. Endometrial biopsies were obtained and enzyme activity is substantially higher in the luteal using Pipelle cannula sampling, and tissue was collected into sterile (secretory) phase of the menstrual cycle (Buirchell and Hähnel, vials containing 250 mmol/l sucrose, 5 mmol/l HEPES, 2 mmol/l 2-1975; Pack et al., 1979) . Experiments in vitro with endometmercaptoethanol, pH 7.4 (Buffer A) and stored at -70°C until use.
rium organ culture and endometrial adenocarcinoma cells
Phase of the menstrual cycle was calculated from the start of the last menstrual period (LMP) and confirmed by standard histological suggest that oestrogen sulphotransferase is regulated by progesanalysis. For data analysis and display the menstrual cycle was divided terone in glandular cells Clarke et al., into five phases: early follicular (EF), days 1-7; late follicular (LF), 1982; Falany and Falany, 1996) , and cyclical changes in days 8-13; early luteal (EL), days 14-18; mid luteal (ML), days 19-glandular and stromal progesterone receptor expression support 24; late luteal (LL), greater than 24 days. For preparation of the cytosolic this (Wang et al., 1998a; Noe et al., 1999 SULT expression in the human endometrium.
substrate (Sharp et al., 1993) . All enzyme assays were optimized for substrate and PAPS concentration, buffer composition, cytosolic protein and incubation time.
Materials and methods
PAP 35 S was used for the assessment of SULT activity towards the substrates: 17β-oestradiol (1.3 µmol/l), phenol (20 µmol/l), 4-nitroSubjects phenol (2 µmol/l), vanillin (20 µmol/l) and dopamine (10 µmol/l). The Three separate groups of subjects were included in the study. The incubation mixture (150 µl) consisted of buffer (60 mmol/l potassium control group comprised 102 fertile women aged between 19 and 51 phosphate, pH 6.0 for 17β-oestradiol; 60 mmol/l Tris/HCl, pH 7.5 for years (mean Ϯ SD ϭ 34.3 Ϯ 6.5 years), with a known history of 4-nitrophenol; 6 mmol/l potassium phosphate, pH 7.0 for phenol and normal conception and childbirth who were undergoing laparoscopic dopamine and 60 mmol/l potassium phosphate pH 6.5 for vanillin), 150 sterilization, hysterectomy or diagnostic laparoscopy. A second group µg of endometrium cytosol protein (100 µg for 17β-oestradiol) substrate comprised 32 women routinely taking the combined oral contraceptive dissolved in propylene glycol (steroids) or water (other substrates), 1 pill (OCP, oestrogen plus progestin) with mean age 29.8 Ϯ 5.3 years mm MgCl 2 , PAPS (0.7 µmol/l for 17β-oestradiol, 10 µmol/l for 4-(range 19-42 years), and the third group comprised 28 women undernitrophenol, 5 µmol/l for phenol, 1.1 µmol/l for dopamine and 1.4 going therapeutic termination of pregnancy (by Gemeprost induction µmol/l for vanillin) and 0.02 µmol/l [ 35 S]PAPS. Cytosols were assayed and suction termination) during the first 6-13 weeks post conception in duplicate with a control incubation containing substrate vehicle only. (mean age 25.1 Ϯ 8.6 years, range 15-42 years). Ethical approval Reactions progressed at 37°C for either 60 min (17β-oestradiol), 45 for the study was obtained from the Tayside Committee on Medical min (4-nitrophenol, vanillin) or 30 min (phenol, dopamine) and were Research Ethics, and informed consent was obtained from each partiterminated by addition of 200 µl 100 mmol/l barium acetate. Unreacted cipant.
PAPS was removed by precipitation with 200 µl 100 mmol/l barium hydroxide and 200 µl 100 mmol/l zinc sulphate and following centrifuMaterials gation for 2 min at 11 000 g. 500 µl of the supernatant were mixed with 4 ml of scintillation fluid (Emuslifier Safe; Canberra Packard, Pipelle cannulae for endometrial biopsy were obtained from Eurosurgical Ltd, Cranleigh, UK. 3Ј-phosphoadenosine 5Ј-phosphosulphate Pangbourne, UK) and radioactivity quantified by liquid scintillation spectrometry. (PAPS), 17β-oestradiol, 17α-ethinyloestradiol, dopamine, dehydroepiandrosterone (DHEA), pregnenolone, vanillin and goat anti-rabbit IgG-3 H-labelled substrates were used to assay SULT activity towards: 17α-ethinyloestradiol (0.5 µmol/l), DHEA (0.4 µmol/l) and pregnenoperoxidase conjugate adsorbed with human serum proteins were obtained from Sigma/Aldrich, Poole, UK. [ 35 S]3Ј-Phosphoadenosine lone (0.67 µmol/l). The incubation mixture (250 µl) comprised: 200 µg endometrium cytosolic protein (300 µg for 17α-oethinylestradiol), 0.1 5Ј-phosphosulphate (PAP 35 S, 1.2-2.4 Ci/mmol), 17α- [6,7,-3 [1, 2, 6, from early and late follicular, and early, mid and late luteal
Immunoblot analysis
endometrium biopsies from fertile women. Figure 1 shows
Endometrial cytosolic proteins were resolved on (SDS)-polyacrylthat enzyme activities for SULT1E1 (A and B), SULT1A1 (C amide gels (11% acrylamide monomer) (Laemmli, 1970) and transand D) and SULT1A3 (E and F) were readily detectable in ferred to nitrocellulose (Towbin et al., 1979) . Immunostaining of SULT endometrium from all stages of the menstrual cycle, whereas was performed using the ECL detection system essentially as described SULT2A1 activity (G and H) was not detectable in any of by the manufacturer (Amersham, Little Chalfont, UK). Primary antithe samples analysed. SULT1E1 activity toward both 17β-bodies used were IgG fractions of rabbit anti-rat liver oestrogen SULT oestradiol and 17α-ethinyl oestradiol was low in the follicular (Borthwick et al., 1993) and rabbit anti-human liver oestrogen SULT (Falany et al., 1995) , and the secondary antibody was a horseradish phase, rose sharply in the early luteal phase and reached a peroxidase-conjugated anti-rabbit IgG adsorbed against human serum peak in the mid luteal phase. Activity towards 4-nitrophenol proteins.
and phenol (SULT1A1) was again lower in the follicular phase than the luteal phase, peaking in the early luteal phase;
Bacterial expression and purification of recombinant human however, the increase in activity between the follicular phase
SULT1E1
and early luteal phase was not as marked as with the substrates An EST (expressed sequence tag) which shared high sequence identity for SULT1E1. In contrast, SULT1A3 activity towards the with the human liver SULT1E1 cDNA (Aksoy et al., 1994; Falany et al., 1995) sion (Song et al., 1998) .
MD, USA) and the insert sequenced using automated sequencing on an
To confirm whether the SULT activity towards oestrogens has been deposited in the EMBL nucleotide sequence database with the (Falany et al., 1995) . Figure 2A and B shows that the antibody accession number Y11195. For expression in E.coli, the coding region recognized a number of polypeptides (there is substantial was (PCR)-amplified (using Bio-X-Act DNA polymerase) from the amino acid sequence identity between members of the human vector using the forward and reverse oligonucleotide primers 5Ј-GTGT-SULT1 family), but the SULT1E1 protein could be identified ACCCATATGAATTCTGA-3Ј and 5Ј-GTAAATCTAGACCTTCTTbased on its co-migration with authentic purified recombinant AGATCT-3Ј which contain recognition sites for the restriction enzymes human SULT1E1. expression (e.g. Figure 2C , r 2 ϭ 0.59, P Ͻ 0.005 by linear ml LB broth containing 100 µg/ml ampicillin were established and regression analysis).
expression was induced by the addition of 2 mmol/l isopropylthiogalactoside. Cells were harvested after incubation at 30°C for 18 h. Recom-
Effect of the combined oral contraceptive pill on
binant protein was purified from lysed E.coli cell pellets by 30-70% sulphotransferase expression in the endometrium ammonium sulphate fractionation followed by ion exchange chromatography on DEAE-Sepharose and affinity chromatography on 3Ј,5Ј-Sulphotransferase enzyme activity was determined in endomet-ADP agarose essentially as described previously (Borthwick et al., rial biopsies from 39 women using the OCP. These biopsies 1993). Purification was monitored using 17β-oestradiol SULT enzyme displayed dramatically reduced sulphotransferase activity assay, SDS (PAGE) and immunoblotting.
towards 17β-oestradiol and 17α-ethinyl oestradiol, substrates for the oestrogen sulphotransferase SULT1E1 ( Figure 3A 
Results
shows data obtained with 17β-oestradiol). To determine whether this effect was also observed with other sulphotransferSulphotransferase enzyme activities and protein expression in the endometrium during the normal ases, SULT enzyme activity was assessed with 4-nitrophenol menstrual cycle (for SULT1A1), dopamine (for SULT1A3) and dehydroepiandrosterone (for SULT2A1). Figure 3B , C and D indicates that, To identify which sulphotransferases are expressed in the human endometrium, we first employed substrates generally in the endometrium from women using the OCP, SULT1A1 activity (4-nitrophenol as substrate) was significantly decreased Sulphotransferase expression in endometrium during early pregnancy (but not abolished), whereas dopamine sulphation (representing SULT1A3) was only slightly reduced (not statistically significAnother major biological effector of endometrial function is ant) and there was no effect on the SULT2A1 activity, which pregnancy, and we therefore determined the effect of pregnancy was still absent from all samples. These data suggest that on oestrogen sulphation in the endometrium. We examined the SULT enzymes are differentially regulated by hormonal the expression of various sulphotransferases in endometrial contraceptives in the endometrium. However, it is not possible biopsies obtained from a group of 28 women undergoing to rule out the influence of gland atrophy under OCP, since therapeutic terminations during the first 6-13 weeks of pregthe site of expression of the individual enzymes is not known.
nancy. As with the OCP, SULT1E1 enzyme activity (as assessed The suppression of SULT1E1 enzyme protein expression was with 17β-oestradiol as substrate) was absent from all 28 confirmed using immunoblot analysis (Figure 4) , which showed samples, whereas SULT1A1 (4-nitrophenol as substrate) and that none of the endometrium samples from women taking the SULT1A3 (vanillin as substrate) activities were virtually unaffected (Table I ). SULT1E1 enzyme protein was also absent from OCP displayed expression of SULT1E1 enzyme protein.
Our results confirm earlier studies (Buirchell and Hähnal, 1975; Tseng and Liu, 1981; Clarke et al., 1982) suggesting that endometrial oestrogen sulphation is tightly associated with the menstrual cycle, being low in the follicular phase and high in the luteal phase. We also extensively studied other sulphotransferase enzyme activities and their in-vivo regulation in the endometrium, using probe substrates that are generally accepted to reflect specific SULT isoforms. The hydroxysteroid sulphotransferase SULT2A1 (or HST) was not expressed in any of the 169 endometrium cytosol samples studied, suggesting that sulphation is not an important modulator of androgen activity in the endometrium. Other androgen-metabolizing enzymes are, however, present in human endometrium. For example 17β-hydroxysteroid dehydrogenase type 2 (Wu et al., 1993) is expressed (under progestin control) (Bonney et al., 1985; Casey et al., 1994) and may ensure minimal androgen (testosterone) synthesis in this tissue, thereby obviating sulphation as a means of modulating androgenic activity. We found that additional members of the phenol sulphotransferase family were expressed at significant levels in the endometrium, as was shown in the Ishikawa endometrial adenocarcinoma cell line (Falany and Falany, 1996) . SULT1A1 and SULT1A3 enzymes appeared less heavily influenced by the phase of the menstrual cycle than SULT1E1, and dopamine sulphation was remarkably constant across all samples studied. The precise function of these enzymes in the endometrium is unknown; however, they are involved in the metabolism of potent endogenous chemicals such as iodothyronines (SULT1A1 and SULT1A3) and catecholamines (SULT1A3). The human endometrium expresses triiodothyronine (T3) receptors (Kirkland et al., 1983) and may therefore be a thyroid hormone-responsive tissue. Sulphation has a dramatic effect on iodothyronine metabolism, blocking the conversion of the prohormone thyroxine (T4) to the receptor active T3 and and mid (B) luteal phase endometrium biopsies from normal accelerating the formation of inactive reverse T3, as well as cycling women were subjected to immunoblot analysis with antidirectly inactivating T3 (Visser, 1994; Visser, 1996) . Thus the SULT1E1 antibody. Lane 1, purified recombinant human embryo expression of these phenol sulphotransferases, which are known SULT1E1 (100 ng). Lanes 2-13 endometrium cytosols (100 µg) to metabolize iodothyronines (Young et al., 1988; Wang et al., from 12 early (A) and mid (B) luteal phase. (C) Linear regression analysis of mid luteal phase endometrium SULT1E1 enzyme 1998b; Kester et al., 1999a) to be the major sulphotransferase involved in sulphation of T4 (Kester et al., 1999b) . Similarly, the endometrium may also be responsive to catecholamines, including dopamine, as there early pregnancy endometrium as assessed using immunoblot is evidence from animal studies of the presence of catecholamanalysis (not shown). Again, SULT2A1 activity (DHEA as ine biosynthetic enzymes and receptors in reproductive tissues substrate) was undetectable in all samples, similar to the (e.g. Mitchell and Ahmed, 1992; Kim et al., 1997) . In humans, control group. This was regardless of the method of termination sulphation is a major pathway of catecholamine metabolism used. Thus, a specific suppression of oestrogen sulphation and inactivation, with Ͼ95% of circulating dopamine existing occurs in the first trimester of pregnancy.
as the sulphate conjugate, which probably originates from extraneuronal tissues including the gastrointestinal tract Discussion (Goldstein et al., 1995; Rubin et al., 1996; Eisenhofer et al., 1997) . It is of course possible that these phenol sulphotransferThe endometrium is a major oestrogen target tissue and many factors control and regulate its response to oestrogenic ases are expressed in the endometrium as part of the body's chemical defence mechanisms directed against toxic or potenstimulation. Metabolism, and inactivating pathways such as sulphate conjugation in particular, exert an important influence tially toxic xenobiotics (Coughtrie, 1996) . Thus the human endometrium is richly endowed with the capacity to sulphate on this response so it is of considerable interest to study sulphation and its regulation in the human endometrium.
endogenous compounds and xenobiotics. In-vitro experiments have demonstrated that oestrogen sulphotransferase activity and expression are induced by progesterone Clarke et al., 1982; Falany and Falany, 1996) , and this is consistent with the cyclical nature of their expression in endometrium biopsy material. However, additional information regarding the regulation of SULT expression in vivo was not available. We therefore studied endometrium SULT expression in women taking the dramatically reduced (OCP). A reduction in endometrial cytoLane 1, purified recombinant human embryo SULT1E1 (100 ng); lane 2, normal mid luteal endometrial cytosol (100 µg); lanes 3-13 sol SULT1A1 enzyme activity was also seen in women taking cytosols (100 µg) from individual OCP user endometrial biopsies. the OCP, but this was not found with SULT1A3 activity. Similarly, early pregnancy did not seem to affect SULT1A1 and SULT1A3 expression. It is possible that changes in endometrium structure (i.e. altered ratio of stromal to glandular with the role of progesterone in the induction of SULT1E1 and Falany, 1996). However, our observations on endometrium from early pregnancy, where SULT1E1 activity was completely tional factors are likely to regulate the expression of this protein in the endometrium. The role of the other sulphotransferases abolished, suggest that the regulation of SULT1E1 expression is more complex. During the first trimester of pregnancy, expressed in the endometrium remains as yet unclear. maternal progesterone concentrations continue to rise from those seen at ovulation, and therefore it might be expected
